ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
Summary
Rosen Law Firm is notifying GeneDx Holdings Corp. investors about an active securities class action and an August 3, 2026 lead plaintiff deadline. The lawsuit centers on claims that GeneDx misrepresented the impact of the Fabric acquisition on its business and financial performance. Investors who bought stock during the class period may be eligible to join the case. The notice explains how to contact counsel and emphasizes that no class has been certified yet.
Classifications
industries
HealthTech
applications
No applications detected
AI Classifications
Labels
Genomics
Genetic Testing
Healthcare Software
Linked Companies
GeneDx
$250M to $500M